American Cannabis Co. (OTCMKTS:AMMJ) is a vertically integrated hemp cannabinoid products company headquartered in New Jersey. The company specializes in the development, manufacturing and distribution of hemp-extracted, plant-based cannabinoid products designed for human and pet consumption. Through its proprietary extraction processes and product formulations, American Cannabis delivers CBD-infused supplements, tinctures, topicals, edibles and vape cartridges that comply with federal and state hemp regulations.
Since its founding, American Cannabis has expanded its product portfolio to serve a diverse range of consumer needs, including sleep support, stress relief and skin health. The company sells under multiple brand names across e-commerce platforms, specialty wellness retailers and veterinary outlets. Its distribution network spans the United States and Canada, with strategic partnerships driving entry into new retail chains and international markets.
Throughout its history, American Cannabis has executed targeted acquisitions and joint ventures to enhance its research and development capabilities. The company’s investments in formulation science and scalable manufacturing facilities enable rapid product innovation, while quality control labs ensure consistency and compliance. Recent initiatives include pilot programs for water-soluble cannabinoids and blended botanical supplements.
Led by CEO Steven White and supported by a management team with extensive experience in consumer packaged goods and regulatory compliance, American Cannabis continues to prioritize supply chain integrity and strategic growth. The company’s leadership emphasizes rigorous testing, transparent sourcing and educational outreach as it seeks to broaden consumer access to safe, hemp-derived wellness solutions.
AI Generated. May Contain Errors.
Free AMMJ Stock Alerts